Corporate
About Medicago
Corporate strategy
Management team
Board of directors
Scientific advisory council
Current partnerships
Technologies
Medicago technologies
Vaccines
Influenza
Pandemic market
Why Plants?
Tobacco
Alfalfa
Why Proficia™?
Why VLPs?
VLPExpress™
Patents/IP
Scientific publications
Manufacturing
Facility overview
Advantages
How does it work?
Products
Product pipeline
Pandemic flu vaccine
Seasonal flu vaccine
Partnering opportunities
Investors
Why invest
Stock quote
Events & presentations
Financial reports
Stockholder information
Analyst coverage
Corporate governance
Glossary of terms
IR contact
RSS feeds
News
News releases
Medicago in the news
Useful links
Partnerships
Current partnerships
Partnership opportunities
Medicago USA
Medicago USA
Local Management Team
Partners
Photo Gallery
News
News releases
Medicago in the news
Useful links
News releases
Medicago in the news
Useful links
Medicago Achieves Positive Preclinical Study Results for Proprietary H5N1 Influenza VLP Vaccine
10/31/2007
Download this Press Release
(PDF 72 KB)
Français
HOME
CAREERS
TERMS OF USE
CONTACT US
Powered By Q4 Web Systems
3.5.18.3156